Free Trial

Eagle Pharmaceuticals (EGRX) Stock Chart & Stock Price History

Eagle Pharmaceuticals logo
$0.88 -0.07 (-6.88%)
As of 03/28/2025 03:50 PM Eastern

Eagle Pharmaceuticals Stock Price Performance

5 Day
Performance
-23.48%
1 Month
Performance
-26.67%
3 Month
Performance
+76.00%
6 Month
Performance
-76.41%
Year-To-Date
Performance
+76.00%
1 Year
Performance
-83.21%
Receive EGRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

EGRX Stock Chart for Sunday, March, 30, 2025

Remove Ads

Eagle Pharmaceuticals Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
03/28/2025$0.95$0.88
-6.88%
$1.00$0.884,000 shs$11.43 million
03/27/2025$1.00$0.95
-5.50%
$1.00$0.89803 shs$12.27 million
03/26/2025$1.15$1.00
-13.04%
$1.00$1.00500 shs$12.99 million
03/25/2025$1.45$1.15
-20.69%
$1.45$1.009,206 shs$14.94 million
03/24/2025$1.49$1.45
-2.68%
$1.45$1.03235 shs$18.83 million
03/21/2025$1.40$1.49
+6.43%
$1.49$1.02314 shs$19.35 million
03/20/2025$1.25$1.40
+12.00%
$1.40$0.87426 shs$18.18 million
03/19/2025$1.30$1.25
-3.85%
$1.27$1.251,433 shs$16.23 million
03/18/2025$1.50$1.30
-13.33%
$1.30$1.031,538 shs$16.88 million
03/17/2025$1.30$1.50
+15.38%
$1.50$0.581,077 shs$19.48 million
03/14/2025$1.30$1.30$1.30$1.04637 shs$16.88 million
03/13/2025$1.30$1.30$1.40$1.042,740 shs$16.88 million
03/12/2025$1.03$1.30
+26.21%
$1.30$1.03940 shs$16.88 million
03/11/2025$1.10$1.03
-6.36%
$1.42$1.03461 shs$13.38 million
03/10/2025$0.85$1.10
+29.41%
$1.10$1.10360 shs$14.29 million
03/07/2025$1.06$0.85
-19.81%
$1.10$0.8519,178 shs$11.04 million
03/06/2025$1.16$1.06
-8.62%
$1.20$1.0514,495 shs$13.77 million
03/05/2025$1.17$1.16
-0.85%
$1.18$1.16483 shs$15.07 million
03/04/2025$1.20$1.17
-2.50%
$1.20$0.822,471 shs$15.20 million
03/03/2025$1.20$1.20$1.20$1.201,063 shs$15.58 million
02/28/2025$1.19$1.20
+0.84%
$1.20$1.201,063 shs$15.58 million

This page (NASDAQ:EGRX) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners